Respiratory syncytial virus in hematopoietic cell transplant recipients: factors determining progression to lower respiratory tract disease.
Respiratory syncytial virus in hematopoietic cell transplant recipients: factors determining progression to lower respiratory tract disease.
复制标题
DOI:
10.1093/infdis/jit832
复制
发表时间:
2014-04-15
期刊:
影响因子:
--
通讯作者:
Boeckh M
中科院分区:
文献类型:
--
作者:
Kim YJ;Guthrie KA;Waghmare A;Walsh EE;Falsey AR;Kuypers J;Cent A;Englund JA;Boeckh M
Background. Respiratory syncytial virus (RSV) lower respiratory tract disease (LRD) is a life-threatening complication in hematopoietic cell transplant (HCT) recipients. Lymphopenia has been associated with an increased risk of progression from upper respiratory tract infection (URI) to LRD. Methods. This study retrospectively analyzed the significance of lymphocyte engraftment dynamics, lung function, smoking history, corticosteroids, antiviral treatment, viral subtypes, and RSV-specific neutralizing antibodies for the progression to LRD in 181 HCT recipients with RSV URI. Results. In multivariable models, smoking history, conditioning with high-dose total body irradiation, and an absolute lymphocyte count (ALC) ≤100/mm3 at the time of URI onset were significantly associated with disease progression. No progression occurred in patients with ALCs of >1000/mm3 at URI onset. Lymphocyte engraftment dynamics were similar in progressors and nonprogressors. Pre- and posttransplant donor and posttransplant recipient RSV subtype-specific neutralizing antibody levels, RSV viral subtypes, and corticosteroids also were not significantly associated with LRD progression. Conclusions. Host and transplant related factors appear to determine the risk of progression to LRD more than viral factors. Dysfunctional cell-mediated immunity appears to be important in the pathogenesis of progressive RSV disease after HCT. A characterization of RSV-specific T-cell immunity is warranted.
登录
查看更多内容
DOI:
10.1016/j.jcv.2004.03.018
发表时间:
2004-10
期刊:
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
影响因子:
--
作者:
Kuypers J;Wright N;Morrow R
通讯作者:
Morrow R
影响因子:
3.6
作者:
Chavez-Bueno, Susana;Mejias, Asuncion;Ramilo, Octavio
通讯作者:
Ramilo, Octavio
影响因子:
12.7
作者:
Canducci, Filippo;Debiaggi, Maurizia;Clementi, Massimo
通讯作者:
Clementi, Massimo
影响因子:
4.3
作者:
Kassis, Christelle;Champlin, Richard E.;Chemaly, Roy F.
通讯作者:
Chemaly, Roy F.
DOI:
10.1093/cid/cis844
发表时间:
2013-01
期刊:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
影响因子:
--
作者:
Hirsch HH;Martino R;Ward KN;Boeckh M;Einsele H;Ljungman P
通讯作者:
Ljungman P